NCT05315908 2024-02-28COVID-19 Testing in Underserved and Vulnerable PopulationsUniversity of California, San DiegoPhase NA Terminated9,120 enrolled 8 charts
NCT02921802 2022-06-14A Study of Special Use Results Surveillance of Revlimid 5mg CapsulesCelgeneCompleted4,626 enrolled
NCT02922543 2022-06-14A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of UseCelgeneCompleted361 enrolled